BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Mistral Pharma Inc. To Present At BioContact Québec 2006

  October 2, 2006

   · 

  1 min read
• Quest PharmaTech Inc. Renegotiates The Terms Of The $1,000,000 Convertible Debenture And Provides Other Corporate Updates

  October 2, 2006

   · 

  1 min read
• GlucoTec, Inc. Named One Of The Finalists For The Innovision Technology Awards Program

  October 2, 2006

   · 

  1 min read
• Business

  ORIDIS Biomed Appoints Wolfgang Senne As Chief Financial Officer

  October 2, 2006

   · 

  3 min read
• Genetown

  GTC Biotherapeutics Says France’s LFB Biotechnologies To Invest $25 Million

  October 2, 2006

   · 

  9 min read
• Business

  Emerging Biopharmaceutical Pharmaxon Announces Completion Of Seed Financing Round

  October 2, 2006

   · 

  1 min read
• Business

  Pioneer Surgical Technology Announces A New Agreement With Regeneration Technologies Inc. To Distribute BioSet(TM) Demineralized Bone Matrix

  October 2, 2006

   · 

  1 min read
• Deals

  Commonwealth Biotechnologies, Inc. Modifies And Extends Term Sheet To Acquire Mimotopes Pty. Ltd.

  October 2, 2006

   · 

  1 min read
• Drug Development

  Merck & Co., Inc. Release: REPEAT/Viral Suppression In Triple-Class Drug Resistant Patients Maintained After 24 Weeks Of Treatment With MK-0518, An Investigational HIV Integrase Inhibitor, Plus Optimized Background Therapy (OBT)

  October 2, 2006

   · 

  6 min read
• Drug Development

  CellGate, Inc. Initiates Innovative Phase Ib Clinical Study Of Anti-proliferative Agent, CGC-11047, In Advanced Solid Tumors And Lymphomas

  October 2, 2006

   · 

  3 min read